Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Rheumatology | Monthly Briefing

Back to Journal Articles

July 2012 Briefing - Rheumatology

Last Updated: August 01, 2012.

 

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 

Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for July 2012. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Self-Efficacy Predicts Fibromyalgia Symptomatology

MONDAY, July 30 (HealthDay News) -- Self-efficacy is a significant predictor of fibromyalgia symptomatology, according to a study published online July 17 in Arthritis Care & Research.

Abstract
Full Text (subscription or payment may be required)

Forefoot Joints Don't Improve 28-Joint Count Measurement

WEDNESDAY, July 25 (HealthDay News) -- For the assessment of patients with early rheumatoid arthritis (RA), including forefoot joints does not significantly improve the precision or range of measurement of the 28-tender and swollen joint count, according to a study published online July 16 in Arthritis Care & Research.

Abstract
Full Text (subscription or payment may be required)

Most Doctors Satisfied With Electronic Health Records

THURSDAY, July 19 (HealthDay News) -- Although only 55 percent of physicians had adopted electronic health records (EHRs) in 2011, most are somewhat or very satisfied with their system and most report enhanced patient care, according to a July data brief issued by the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics (NCHS).

More Information

~12,000 Preventable Deaths in English Hospitals Annually

THURSDAY, July 19 (HealthDay News) -- Approximately 12,000 hospital deaths in England each year are preventable, according to research published online July 7 in BMJ Quality & Safety.

Abstract
Full Text (subscription or payment may be required)

Discrepancy in Perception of RA Disease Activity Elucidated

THURSDAY, July 19 (HealthDay News) -- Patients with rheumatoid arthritis (RA) see pain as the most significant determinant of their disease activity, while physicians see joint swelling as the most important determinant, according to a study published online July 18 in Arthritis & Rheumatism.

Abstract
Full Text (subscription or payment may be required)

ANCA-Associated Vasculitis Has Genetic Component

THURSDAY, July 19 (HealthDay News) -- A genome-wide association study of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis shows a genetic contribution to disease susceptibility, which differs between granulomatosis with polyangiitis and microscopic polyangiitis, according to a study published in the July 19 issue of the New England Journal of Medicine.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Poorer Patient Experience at Safety-Net Hospitals

THURSDAY, July 19 (HealthDay News) -- Safety-net hospitals (SNHs) perform worse on nearly every measure of patient experience, according to a study published online July 16 in the Archives of Internal Medicine.

Abstract
Full Text
Editorial

Chronic Periodontitis Increases Risk of Psoriasis

THURSDAY, July 19 (HealthDay News) -- Patients with chronic periodontitis (CP) are 1.5 times more likely to be diagnosed with psoriasis, and this risk is lessened but not nullified by CP treatment using gingivectomy or periodontal flap operation, according to research published online July 3 in the British Journal of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Social Network Analysis IDs Informal Physician Networks

TUESDAY, July 17 (HealthDay News) -- Informal networks among physicians who share patients demonstrate substantial geographic variability, while within networks, physician and patient characteristics are similar, according to a study published in the July 18 issue of the Journal of the American Medical Association.

Abstract
Full Text
Editorial

Prevalence of Gout Increases With Increasing BMI

TUESDAY, July 17 (HealthDay News) -- Having an increased body mass index (BMI) correlates with increased prevalence of gout in adults, according to study published online July 6 in Arthritis Care & Research.

Abstract
Full Text (subscription or payment may be required)

RA Patients Are Receiving Recommended Cancer Screenings

THURSDAY, July 12 (HealthDay News) -- Patients with rheumatoid arthritis (RA) receive cancer screening tests at higher rates than that of the general population, according to a study published online July 10 in Arthritis & Rheumatism.

Abstract
Full Text (subscription or payment may be required)

Moderate Drinking Cuts Risk of Rheumatoid Arthritis in Women

WEDNESDAY, July 11 (HealthDay News) -- Moderate alcohol consumption correlates with reduced incidence of rheumatoid arthritis (RA) among women, according to a study published online July 10 in BMJ.

Full Text

Anxiety, Depression Common in Adults With Arthritis

MONDAY, July 9 (HealthDay News) -- Anxiety and depression are both common among U.S. adults with arthritis, with anxiety found more often than depression, according to a study published in the July issue of Arthritis Care & Research.

Abstract
Full Text (subscription or payment may be required)

Gastrointestinal Perforation Rare in Rheumatoid Arthritis

FRIDAY, July 6 (HealthDay News) -- Gastrointestinal (GI) perforation is a rare but serious condition that affects patients with rheumatoid arthritis (RA), most frequently in the lower GI tract, according to a study published online June 21 in Arthritis Care & Research.

Abstract
Full Text (subscription or payment may be required)

Obesity Is a Risk Factor for Poor Remission Rates in RA

FRIDAY, July 6 (HealthDay News) -- For patients with long-standing rheumatoid arthritis treated with anti-tumor necrosis factor-α (anti-TNFα) therapies, obesity is related to poor remission rates, according to a study published online June 21 in Arthritis Care & Research.

Abstract
Full Text (subscription or payment may be required)

Positive Outcome No More Likely in Industry-Funded Trials

THURSDAY, July 5 (HealthDay News) -- Industry-sponsored clinical trials of rheumatoid arthritis drugs are no more likely to report positive outcomes than trials funded by other means, and in many cases use better methodology, according to research published in the July issue of Arthritis & Rheumatism.

Abstract
Full Text (subscription or payment may be required)

No Increase in Shingles After Vaccine in Those on Biologics

TUESDAY, July 3 (HealthDay News) -- Live attenuated herpes zoster (HZ) vaccine is not associated with an increased risk of HZ shortly after vaccination in patients treated with biologics for immune-mediated diseases, according to a study published in the July 4 issue of the Journal of the American Medical Association.

Abstract
Full Text

Novel Susceptibility Loci Identified for Osteoarthritis

TUESDAY, July 3 (HealthDay News) -- Five novel single nucleotide polymorphisms (SNPs) are significantly associated with osteoarthritis, including one near the nucleostemin-encoding gene, according to a study published online July 3 in The Lancet.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Rheumatoid Arthritis Drug Not Linked to Specific Birth Defects

TUESDAY, July 3 (HealthDay News) -- The rheumatoid arthritis drug leflunomide is not a major cause of birth defects in women who inadvertently become pregnant while taking the drug, although pregnancy should be avoided, according to a study in the July issue of Arthritis & Rheumatism.

Abstract
Full Text (subscription or payment may be required)

Standardized Treatment Plans Developed for New-Onset JIA

MONDAY, July 2 (HealthDay News) -- Four standardized consensus treatment plans (CTPs) have been developed for patients with new-onset systemic juvenile idiopathic arthritis (JIA), according to research published in the July issue of Arthritis Care & Research.

Abstract
Full Text (subscription or payment may be required)

Long-Term Rituximab Safe for Patients With Wegener's

MONDAY, July 2 (HealthDay News) -- Repeated and prolonged use of rituximab for B-cell depletion to treat relapses or maintain remission is safe and effective in patients with refractory granulomatosis with polyangiitis (GPA; Wegener's), a primary systemic small vessel vasculitis, according to a study published online June 21 in Arthritis & Rheumatism.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 ScoutNews, LLC. All rights reserved.


Previous: July 2012 Briefing - Pulmonology Next: July 2012 Briefing - Surgery

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.